Recombinant Factor VIIa and Tranexamic Acid in Subgaleal Hemorrhage
Journal of Pediatrics & Neonatal Biology · 2016
DOI: 10.33140/jpnb.01.01.05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatrics & Neonatal Biology, 2016. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Subgaleal hemorrhage (SGH) is a severe condition associated with a 5-14% risk of neonatal death. SGH has been described as a complication of birth by vacuum extraction; however it can occur with any mode of delivery. The spectrum of clinical severity varies from mildly asymptomatic to severe, with hemorrhagic shock, coagulopathy and end organ injury. Early recognition of symptoms, prompt restoration of circulatory volume and control of bleeding could improve outcomes [1].
Zitieren
APA
(2016). Recombinant Factor VIIa and Tranexamic Acid in Subgaleal Hemorrhage. Journal of Pediatrics & Neonatal Biology. https://doi.org/10.33140/jpnb.01.01.05
Vancouver
Recombinant Factor VIIa and Tranexamic Acid in Subgaleal Hemorrhage. Journal of Pediatrics & Neonatal Biology. 2016. doi:10.33140/jpnb.01.01.05
BibTeX
@article{euvimed2016,
title = {Recombinant Factor VIIa and Tranexamic Acid in Subgaleal Hemorrhage},
journal = {Journal of Pediatrics & Neonatal Biology},
year = {2016},
doi = {10.33140/jpnb.01.01.05}
}
EUVIMED